Episode

403: Biotech exec Jeremy Levin on the industry's strategic turning point

Podcast
The Readout Loud
Published
May 28, 2026
Duration seconds
2842
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/TTSAA7370303095.mp3
Audio
https://traffic.megaphone.fm/TTSAA7370303095.mp3
JSON
/v1/public/podcasts/the-readout-loud-1134305/episodes/403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point
Markdown
/podcast/the-readout-loud-1134305/403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-readout-loud-1134305/403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

On this week’s episode of “The Readout LOUD,” we chat with longtime biotech executive Jeremy Levin about his new book, “Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust.” That sounds alarmist, and it is in some respects, but as Levin explains, the book is also a roadmap to a brighter future for the biotech industry.